You are here
Clinical Trials: Brain Diseases
Discuss
Each Clinical Trial will open in a new browser window or tab.
Condition: Acute Ischemic Stroke
Intervention: Biological: HPC, Cord Blood
Sponsor: BHI Therapeutic Sciences
Not yet recruiting
Intervention: Biological: HPC, Cord Blood
Sponsor: BHI Therapeutic Sciences
Not yet recruiting
Condition: Stroke, Ischemic
Intervention: Biological: Induction of neural stem cells
Sponsor: Allife Medical Science and Technology Co., Ltd.
Not yet recruiting
Intervention: Biological: Induction of neural stem cells
Sponsor: Allife Medical Science and Technology Co., Ltd.
Not yet recruiting
Conditions: Alzheimer Disease; Alzheimer Dementia; Vascular Dementia; Lewy Body Disease; Lewy Body Dementia With Behavioral Disturbance (Disorder); Dementia, Mixed; Parkinson-Dementia Syndrome; Chronic Traumatic Encephalopathy; Huntington's Dementia; Wernicke Korsakoff Syndrome; Traumatic Brain Injury; Dementia, Multi-Infarct; Autism; Autism Spectrum Disorder; Autistic Behavior; Autistic Disorder, Current or Active State
Interventions: Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Near Infrared Light
Sponsor: MD Stem Cells
Recruiting
Interventions: Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction; Procedure: Near Infrared Light
Sponsor: MD Stem Cells
Recruiting
Conditions: Safety Issues; Effect of Drugs
Interventions: Other: autologous umbilical cord blood stem cells; Drug: 0.9% Sodium-chloride
Sponsor: Guangdong Women and Children Hospital
Not yet recruiting
Interventions: Other: autologous umbilical cord blood stem cells; Drug: 0.9% Sodium-chloride
Sponsor: Guangdong Women and Children Hospital
Not yet recruiting
Condition: Parkinson Disease
Intervention: Biological: Injection of Umbilical cord derived MSCs
Sponsor: University of Jordan
Recruiting
Intervention: Biological: Injection of Umbilical cord derived MSCs
Sponsor: University of Jordan
Recruiting
Conditions: Ischemic Stroke; Chronic Stroke; Hemiparesis; Arm Paralysis
Interventions: Combination Product: CTX0E03 Drug Product and delivery device; Drug: Placebo
Sponsor: ReNeuron Limited
Not yet recruiting
Interventions: Combination Product: CTX0E03 Drug Product and delivery device; Drug: Placebo
Sponsor: ReNeuron Limited
Not yet recruiting
Condition: Stroke
Intervention: Device: Virtual Reality Mirror Therapy
Sponsors: Columbia University; Realiteer Corp.
Recruiting
Intervention: Device: Virtual Reality Mirror Therapy
Sponsors: Columbia University; Realiteer Corp.
Recruiting
Condition: Stroke
Interventions: Drug: Adipose derived Stem Cell; Drug: placebo
Sponsors: University Hospital, Grenoble; European Commission H2020 program; University Grenoble Alps; Servicio Madrileño de Salud, Madrid, Spain; Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic; Andaluz Health Service; University of Glasgow; University of Eastern Finland; Etablissement Français du Sang; University of Tampere; Histocell SL, Spain; Medfiles CRO, Finland; Institut National de la Santé Et de la Recherche Médicale, France; Hospices Civils de Lyon; Association groupe ESSEC, France; NOVADISCOVERY SAS, France; FINOVATIS, France; CHU Besancon, France; Assistance Publique - Hôpitaux de Paris; CHU Toulouse, France; CHU Bordeaux, France; CHU Cote de Nacre, Caen, France; Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Servicio de Salud de Castilla La Mancha, Albacete, Spain; Servizo Galego de Saude, Santiago de Compostela, Spain; Pirkanmaa Hospital District, Tampere, Finland; Hospital Vall d'Hebron; Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta; CH Sainte-Anne, Paris, France
Recruiting
Interventions: Drug: Adipose derived Stem Cell; Drug: placebo
Sponsors: University Hospital, Grenoble; European Commission H2020 program; University Grenoble Alps; Servicio Madrileño de Salud, Madrid, Spain; Fakultni Nemocnice U Sv. Anny v Brne, Brno, Czech Republic; Andaluz Health Service; University of Glasgow; University of Eastern Finland; Etablissement Français du Sang; University of Tampere; Histocell SL, Spain; Medfiles CRO, Finland; Institut National de la Santé Et de la Recherche Médicale, France; Hospices Civils de Lyon; Association groupe ESSEC, France; NOVADISCOVERY SAS, France; FINOVATIS, France; CHU Besancon, France; Assistance Publique - Hôpitaux de Paris; CHU Toulouse, France; CHU Bordeaux, France; CHU Cote de Nacre, Caen, France; Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León; Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Servicio de Salud de Castilla La Mancha, Albacete, Spain; Servizo Galego de Saude, Santiago de Compostela, Spain; Pirkanmaa Hospital District, Tampere, Finland; Hospital Vall d'Hebron; Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta; CH Sainte-Anne, Paris, France
Recruiting
Condition: Parkinson's Disease
Intervention: Biological: mesenchymal stem cells
Sponsor: Hebei Newtherapy BIo-Pharma technology Co., Ltd.
Recruiting
Intervention: Biological: mesenchymal stem cells
Sponsor: Hebei Newtherapy BIo-Pharma technology Co., Ltd.
Recruiting
Condition: Ischemic Stroke
Interventions: Biological: MultiStem; Biological: Placebo
Sponsors: Athersys, Inc; Medpace, Inc.
Not yet recruiting
Interventions: Biological: MultiStem; Biological: Placebo
Sponsors: Athersys, Inc; Medpace, Inc.
Not yet recruiting
